Deze Pharmacy

PharmaceuticalsSeries ADalian, China

Latest round

Series A

Last raised

Feb 2015

Total raised

Undisclosed

Investors

2

About Deze Pharmacy

Based in Dalian, China and established in 1998, Deze Pharmacy is a healthcare company that focuses on antitumor drug development. Deze Pharmacy integrates the manufacture, research and development, and sales of drug. The company's production range includes small volume injections (anti-tumor drugs), combinations and oral emulsions (anti-tumor drugs), and APIs (elemene). The company generates revenue by developing and selling anti-tumor botanicals and therapeutic emulsions.

Who invested in Deze Pharmacy

2 investors across 1 round

See all investors in Deze Pharmacy

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Feb 9, 2015

    Amount

    Undisclosed

    Investors

    Locked

Questions about Deze Pharmacy

Who invested in Deze Pharmacy?

Deze Pharmacy has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Deze Pharmacy raised?

Deze Pharmacy has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Deze Pharmacy last raise money?

Deze Pharmacy's most recent round on record is a Series A, in Feb 2015.

What does Deze Pharmacy do?

Based in Dalian, China and established in 1998, Deze Pharmacy is a healthcare company that focuses on antitumor drug development.

Where is Deze Pharmacy headquartered?

Deze Pharmacy is headquartered in Dalian, China.

Which VCs invest in companies like Deze Pharmacy?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Deze Pharmacy's stage. Their profiles are linked below.

Raising like Deze Pharmacy? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.